AJMC November 11, 2020
In a pair of sessions at the Quality Cancer Care Alliance Virtual Fall Leadership Summit, speakers discussed the promise of precision medicine for not only informing individuals’ cancer treatment decisions but also identifying individuals at high risk before disease develops.
Keynote speaker Michael Snyder, PhD, professor and chair of genetics at the Stanford University School of Medicine and director of the Stanford Center for Genomics and Personalized Medicine, kicked off his talk by arguing that we are not providing individual-based precision medicine to the fullest possible extent. Using temperature as an example, he said that we should get to know individuals’ personal baselines, rather than using population-based averages, to detect disease at its earliest moments.
Snyder also spoke of the...
Today's Sponsors
Today's Sponsor